Recently, Dr. Oliver Bruns joined the new Helmholtz Pioneer Campus, where he aims to visualize processes in living organisms. Together with his former...
Matthias Meier is pursuing ambitious goals. Based on his own, sophisticated organ on a chip system, the new team leader at Helmholtz Pioneer Campus...
Globally leading experts in Diabetes, Metabolism and Biomedical Engineering meet to discuss future concepts for Precision Medicine
New technologies enable deeper insights into the causes of major diseases such as diabetes, obesity or cancer and open the way to a new generation of...
We are looking for a motivated postdoctoral fellow interested in the mechanisms of gene regulation in neural development. The goal of this project is...
We are looking for a highly motivated PhD student interested in the epigenetic mechanisms of gene regulation in neural development. The goal of this...
We are looking for a highly motivated PhD student interested in the functional consequences of 3D genome evolution. The goal of this project is to...
We are looking for a self-motivated, enthusiastic lab manager with scientific curiosity, effective communication skills, attention to detail, and...
The Helmholtz Pioneer Campus (HPC) leadership is excited to unveil an HPC-specific corporate design that will be invaluable for introducing the new...
The Helmholtz Pioneer Campus
HPC is an innovation campus with a startup culture, routed in the Helmholtz Zentrum Munich and part of the Helmholtz Association, Germany’s largest research community. HPC stands for the smart fusion of biomedical sciences, engineering and digitization in a research environment that has no parallel in Europe. Helmholtz Pioneers pave the way for tomorrow’s biomedical breakthroughs. Teams of top scientific talents from all over the world work together on the development of novel solutions that make a difference in the prevention, diagnosis and treatment of metabolic diseases. HPC gets its name from Hermann von Helmholtz (1821- 1894), a physician and physicist, polymath and science pioneer. HPC aspires to the research excellence Helmholtz embodies.
We are pioneers, our mission is ...
... driving discovery
We address the big challenges in biomedicine and engineer novel solutions that enable decisive breakthroughs in metabolic disease prevention, diagnosis and treatment. Research that pushes boundaries is our passion.
HPC Future Research Areas
Microfluidics, Organ on-chip Matthias Meier, Stanford*
Next Generation in-vivo Brain Imaging Ryan Remedios, Caltech*
Bio-Sensing, Bio-Imaging Oliver Bruns, MIT*
Material- and Tissue Engineering Jian Cui
Molecular Aging, Single-cell Heterogeneity Celia Martinez-Jimenez, CRUK*
3D-Genome Architecture, Bio-Computation Boyan Bonev, CNRS*
*affiliation before joining HPC
... facilitating discovery
We enable intellectual freedom with flat organizational structures, less bureaucracy and open communication channels. We provide creative space with exceptional resources and leading-edge infrastructure.
- Substantial start-up and running costs for innovative pioneer teams with no teaching obligations.
- Funding has been secured for a state of the art research building hosting up to 20 teams with scheduled opening in 2021.
- We are testing digital processes for effective interdisciplinary research and efficient science administration.
- We are based in Munich, European hub for engineering, life sciences and IT and voted one of the the most liveable cities in the world (Mercer ranking).
... accelerating discovery
We create new tools and technologies in interdisciplinary teams combining the skills of exceptional engineers, biologists, physicists, physicians and data specialists.
... communicating discovery
We share our expertise and methods within the Helmholtz Association as well as local and global (academic, corporate, societal) partners, providing impetus and inspiration for future medicines to improve societal health.
HPC Conferences & Networks
Successful international conferences
- Annual Helmholtz-Nature Medicine Conferences since 2013
- Coming soon: Global Keystone Conference in Munich: „Engineering Biomedical Breakthroughs“
Stephen Quake, CZ Biohub Stanford · Katia Karalis, Emulate Inc. · L. Boyer, MIT · M. Haigis, Harvard · F. Slack, Harvard · P. Frenette Einstein · S. Raffii, Weill Cornell · A. Giraldez, Yale · O. Shirihai, UCLA · M.Teitell, UCLA · K. Plath, UCLA · F. de Sauvage, Genentech